Next Article in Journal
Nanotechnology and Drug Delivery: An Update in Oncology
Next Article in Special Issue
Design, Synthesis, and Biological Evaluation of PKD Inhibitors
Previous Article in Journal
Efficient Gene Silencing by Self-Assembled Complexes of siRNA and Symmetrical Fatty Acid Amides of Spermine
Previous Article in Special Issue
Cell Migration and Invasion Assays as Tools for Drug Discovery
Pharmaceutics 2011, 3(2), 141-170; doi:10.3390/pharmaceutics3020141
Review

Live Cell in Vitro and in Vivo Imaging Applications: Accelerating Drug Discovery

1
, 2
, 2
, 2
, 3
, 3
, 3
 and 3,*
Received: 14 February 2011; in revised form: 21 March 2011 / Accepted: 31 March 2011 / Published: 4 April 2011
(This article belongs to the Special Issue Drug Discovery Tools)
View Full-Text   |   Download PDF [2094 KB, updated 6 April 2011; original version uploaded 4 April 2011]   |   Browse Figures
Abstract: Dynamic regulation of specific molecular processes and cellular phenotypes in live cell systems reveal unique insights into cell fate and drug pharmacology that are not gained from traditional fixed endpoint assays. Recent advances in microscopic imaging platform technology combined with the development of novel optical biosensors and sophisticated image analysis solutions have increased the scope of live cell imaging applications in drug discovery. We highlight recent literature examples where live cell imaging has uncovered novel insight into biological mechanism or drug mode-of-action. We survey distinct types of optical biosensors and associated analytical methods for monitoring molecular dynamics, in vitro and in vivo. We describe the recent expansion of live cell imaging into automated target validation and drug screening activities through the development of dedicated brightfield and fluorescence kinetic imaging platforms. We provide specific examples of how temporal profiling of phenotypic response signatures using such kinetic imaging platforms can increase the value of in vitro high-content screening. Finally, we offer a prospective view of how further application and development of live cell imaging technology and reagents can accelerate preclinical lead optimization cycles and enhance the in vitro to in vivo translation of drug candidates.
Keywords: imaging; intravital; high-content; temporal; fluorescence; drug discovery; biomarkers; translation; efficacy imaging; intravital; high-content; temporal; fluorescence; drug discovery; biomarkers; translation; efficacy
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Isherwood, B.; Timpson, P.; McGhee, E.J.; Anderson, K.I.; Canel, M.; Serrels, A.; Brunton, V.G.; Carragher, N.O. Live Cell in Vitro and in Vivo Imaging Applications: Accelerating Drug Discovery. Pharmaceutics 2011, 3, 141-170.

AMA Style

Isherwood B, Timpson P, McGhee EJ, Anderson KI, Canel M, Serrels A, Brunton VG, Carragher NO. Live Cell in Vitro and in Vivo Imaging Applications: Accelerating Drug Discovery. Pharmaceutics. 2011; 3(2):141-170.

Chicago/Turabian Style

Isherwood, Beverley; Timpson, Paul; McGhee, Ewan J; Anderson, Kurt I; Canel, Marta; Serrels, Alan; Brunton, Valerie G; Carragher, Neil O. 2011. "Live Cell in Vitro and in Vivo Imaging Applications: Accelerating Drug Discovery." Pharmaceutics 3, no. 2: 141-170.


Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert